The site will be unavailable from 11:00 PM GMT on Tuesday, 21 July 2026, until 4:00 AM GMT on Wednesday, 22 July 2026, due to scheduled maintenance.

transplant eligible

8th Nov 2024

Final analysis of the GRIFFIN study: Daratumumab with lenalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma